BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12032831)

  • 1. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions.
    Wu WS; Xu ZX; Ran R; Meng F; Chang KS
    Oncogene; 2002 May; 21(24):3925-33. PubMed ID: 12032831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation.
    Song KH; Park YY; Park KC; Hong CY; Park JH; Shong M; Lee K; Choi HS
    Mol Endocrinol; 2004 Aug; 18(8):1929-40. PubMed ID: 15155786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment.
    Wansa KD; Harris JM; Muscat GE
    J Biol Chem; 2002 Sep; 277(36):33001-11. PubMed ID: 12082103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter.
    Vallian S; Chin KV; Chang KS
    Mol Cell Biol; 1998 Dec; 18(12):7147-56. PubMed ID: 9819401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
    Kim EJ; Park JS; Um SJ
    Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivation.
    Park KC; Song KH; Chung HK; Kim H; Kim DW; Song JH; Hwang ES; Jung HS; Park SH; Bae I; Lee IK; Choi HS; Shong M
    Mol Endocrinol; 2005 Jan; 19(1):12-24. PubMed ID: 15459248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coiled-coil domain is the structural determinant for mammalian homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein and other tripartite motif proteins by the proteasome.
    Fanelli M; Fantozzi A; De Luca P; Caprodossi S; Matsuzawa S; Lazar MA; Pelicci PG; Minucci S
    J Biol Chem; 2004 Feb; 279(7):5374-9. PubMed ID: 14645235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative cross-talk between Nur77 and small heterodimer partner and its role in apoptotic cell death of hepatoma cells.
    Yeo MG; Yoo YG; Choi HS; Pak YK; Lee MO
    Mol Endocrinol; 2005 Apr; 19(4):950-63. PubMed ID: 15625237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nur77 forms novel nuclear structures upon DNA damage that cause transcriptional arrest.
    de Léséleuc L; Denis F
    Exp Cell Res; 2006 May; 312(9):1507-13. PubMed ID: 16480977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein.
    Tsuzuki S; Towatari M; Saito H; Enver T
    Mol Cell Biol; 2000 Sep; 20(17):6276-86. PubMed ID: 10938104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis.
    Youn HD; Chatila TA; Liu JO
    EMBO J; 2000 Aug; 19(16):4323-31. PubMed ID: 10944115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2.
    Yang S; Kuo C; Bisi JE; Kim MK
    Nat Cell Biol; 2002 Nov; 4(11):865-70. PubMed ID: 12402044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein.
    Vallian S; Gäken JA; Gingold EB; Kouzarides T; Chang KS; Farzaneh F
    Oncogene; 1998 Jun; 16(22):2843-53. PubMed ID: 9671405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant association of promyelocytic leukemia protein-retinoic acid receptor-alpha with coactivators contributes to its ability to regulate gene expression.
    Reineke EL; Liu H; Lam M; Liu Y; Kao HY
    J Biol Chem; 2007 Jun; 282(25):18584-18596. PubMed ID: 17475621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
    Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
    Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear-cytoplasmic shuttling of a RING-IBR protein RBCK1 and its functional interaction with nuclear body proteins.
    Tatematsu K; Yoshimoto N; Koyanagi T; Tokunaga C; Tachibana T; Yoneda Y; Yoshida M; Okajima T; Tanizawa K; Kuroda S
    J Biol Chem; 2005 Jun; 280(24):22937-44. PubMed ID: 15833741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Nur77 by selected 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways.
    Chintharlapalli S; Burghardt R; Papineni S; Ramaiah S; Yoon K; Safe S
    J Biol Chem; 2005 Jul; 280(26):24903-14. PubMed ID: 15871945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel function of orphan nuclear receptor Nur77 in stabilizing hypoxia-inducible factor-1alpha.
    Yoo YG; Yeo MG; Kim DK; Park H; Lee MO
    J Biol Chem; 2004 Dec; 279(51):53365-73. PubMed ID: 15385570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
    Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
    Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
    Fuchs O; Provazníková D; Peslová G
    Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.